Clinical Trial Update: Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 study assessing continuous or intermittent S-1 plus oxaliplatin for recurrent or metastatic gastric cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Stomach Neoplasms | Phase 2 | Status: UNKNOWN